PER
Click for more information
4.65% 9.0¢ percheron therapeutics limited

Ann: Long COVID study identifies diagnostic & therapeutic targets, page-10

  1. dalts66
    4,358 Posts.
    lightbulb Created with Sketch. 2033
    clock Created with Sketch.
    21/08/22
    20:06
    Post #: 63236629
    How good would that be.

    And then on a completely different indication, a gene therapy treatment that has some safety concerns, may be able to lower their dose amount, when combined with ATL1102. helping safety. helping efficacy.

    And then there are the other indications, and that approval trial for DMD in non ambulant boys.

    Exciting 18 months to come.
    Likes Created with Sketch. 9  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS A$17 Million Cash Sale of Citadel Joint Venture Interest
right-arrow Created with Sketch.
NEWS Rock Chip results up to 170g/t Au on Komboro at Napie
right-arrow Created with Sketch.
NEWS PLS: HotCopper's Most Discussed Stock of The Week!
right-arrow Created with Sketch.
NEWS Exceptional lithium assays uncovered at Falcon Lake – expanding mineralisation, big potential ahead
right-arrow Created with Sketch.
NEWS US fracking support boosts outlook for Australian gas stocks
right-arrow Created with Sketch.
NEWS Week 37 Wrap: HotCopper likes Cuban oil; markets shrug debate off for Putin; firebrand quant says social media a market threat
right-arrow Created with Sketch.
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
9.0¢ 		Change
0.004(4.65%) 		Mkt cap ! $81.13M
Open High Low Value Volume
8.6¢ 9.1¢ 8.5¢ $181.6K 2.049M

Buyers (Bids)

No. Vol. Price($)
1 10344 8.7¢
 

Sellers (Offers)

Price($) Vol. No.
9.0¢ 64275 1
View Market Depth
Last trade - 16.10pm 13/09/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.